Takasumi Mika, Hikichi Takuto, Takagi Tadayuki, Suzuki Rei, Watanabe Ko, Nakamura Jun, Sugimoto Mitsuru, Kikuchi Hitomi, Konno Naoki, Waragai Yuichi, Asama Hiroyuki, Obara Katsutoshi, Ohira Hiromasa
Department of Gastroenterology, Fukushima Medical University School of Medicine.
Department of Endoscopy, Fukushima Medical University Hospital.
Fukushima J Med Sci. 2017 Aug 9;63(2):75-80. doi: 10.5387/fms.2015-21. Epub 2017 Jul 5.
Schwannomas are difficult to diagnose using imaging alone. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is an effective and safe tissue sampling technique. Nevertheless, few reports have described EUS-FNA for schwannoma.
This study evaluates the efficacy of EUS-FNA for diagnosing schwannoma.
This retrospective study examined six consecutive schwannoma patients who were diagnosed as having schwannoma either from EUS-FNA results or from surgically resected specimens. The primary endpoint was diagnostic accuracy of EUS-FNA for schwannoma. The secondary endpoint was EUS-FNA safety.
Based on cytomorphologic features and immunocytochemistry results after EUS-FNA, 4 out of 6 patients (66.7%) were diagnosed with schwannoma. The diagnoses before EUS-FNA were the following: 3 cases of gastric subepithelial lesion (SEL, suspicious for gastrointestinal stromal tumor), 1 case of intraperitoneal tumor, 1 case of retroperitoneal tumor, and 1 case of pancreatic tumor, with sizes of 15-44 mm (median 36 mm). No case was diagnosed as schwannoma solely based on image findings. Two cases of gastric SELs could not be diagnosed as schwannoma by EUS-FNA before surgery. Inadequate sampling and a lack of additional material for immunohistochemical studies could have engendered less-definite diagnoses in those cases. No procedural adverse events occurred.
The diagnostic accuracy rate of EUS-FNA for schwannoma is somewhat low. However, tissue samples were obtained safely using this method. Moreover, it is an important procedure for diagnosing schwannoma, which cannot be diagnosed solely from image findings.
仅通过影像学检查很难诊断神经鞘瘤。内镜超声引导下细针穿刺抽吸术(EUS-FNA)是一种有效且安全的组织采样技术。然而,很少有报道描述EUS-FNA用于神经鞘瘤的情况。
本研究评估EUS-FNA诊断神经鞘瘤的有效性。
这项回顾性研究检查了6例连续的神经鞘瘤患者,这些患者通过EUS-FNA结果或手术切除标本被诊断为神经鞘瘤。主要终点是EUS-FNA对神经鞘瘤的诊断准确性。次要终点是EUS-FNA的安全性。
根据EUS-FNA后的细胞形态学特征和免疫细胞化学结果,6例患者中有4例(66.7%)被诊断为神经鞘瘤。EUS-FNA前的诊断如下:3例胃上皮下病变(SEL,怀疑为胃肠道间质瘤),1例腹腔内肿瘤,1例腹膜后肿瘤,1例胰腺肿瘤,大小为15-44mm(中位数36mm)。没有病例仅根据影像学表现被诊断为神经鞘瘤。2例胃SEL在手术前通过EUS-FNA无法诊断为神经鞘瘤。采样不足和缺乏用于免疫组织化学研究的额外材料可能导致这些病例的诊断不明确。未发生手术相关不良事件。
EUS-FNA对神经鞘瘤的诊断准确率较低。然而,使用该方法能够安全地获取组织样本。此外,它是诊断神经鞘瘤的重要手段,因为仅靠影像学表现无法诊断神经鞘瘤。